Is this the Year for Psychedelics? A Glimpse into Medicine’s Future in 2024
In 1988 we got Prozac®…a game-changing depression treatment. In 2008 the FDA approved TMS therapy… the first FDA-cleared in-office neuromodulation depression treatment. In 2019, the next advancement, Spravato® was approved by the FDA, in conjunction with an oral antidepressant, for the treatment of adults with treatment-resistant depression. Currently, among the whirlwind of groundbreaking advancements, psychedelics […]